A retrospective trial evaluating the long-term efficacy, safety and prognostic factors of low dose triple therapy of gabapentin or pregabalin, amitriptyline, and non- steroidal anti-inflammatory drugs in patients with bladder pain syndrome/interstitial cystitis

Trial Profile

A retrospective trial evaluating the long-term efficacy, safety and prognostic factors of low dose triple therapy of gabapentin or pregabalin, amitriptyline, and non- steroidal anti-inflammatory drugs in patients with bladder pain syndrome/interstitial cystitis

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Oct 2016

At a glance

  • Drugs Amitriptyline; Gabapentin; Pregabalin
  • Indications Interstitial cystitis; Pain
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 24 Oct 2016 New trial record
    • 16 Sep 2016 Long-term treatment outcomes, recurrence, adverse effects, and prognostic factors results (n=113) presented at the 46th Annual Meeting of the International Continence Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top